Washington, D.C., April 23, 2024 (GLOBE NEWSWIRE) The Muscular Dystrophy Association (MDA) is proud to announce the launch of its latest MDA Advocacy initiative, the ‘Access The Vote’ Campaign,
New York, Sept. 28, 2023 (GLOBE NEWSWIRE) The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg